• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Replies
16
Views
2K
Replies
12
Views
1K
Replies
4K
Views
1M
Replies
1K
Views
479K
Replies
2
Views
334
Replies
71
Views
9K